Marianne Terndrup Pedersen

Marianne Terndrup Pedersen has a diverse background in the field of biology and research. Marianne Terndrup is currently working at Muna Therapeutics since October 2022, holding the position of Biology Lead. Prior to this, they were employed at Orphazyme A/S from June 2020 to September 2021, where they served as an Associate Principal Scientist and later as a Senior Scientist. Marianne also took time off for maternity leave from April 2021 to January 2022. Marianne Terndrup has extensive experience in academia, having worked at the Biotech Research & Innovation Centre (BRIC), University of Copenhagen, from December 2015 to June 2020, as an Assistant Professor conducting research projects and supervising students. Marianne Terndrup had previously worked as a postdoctoral researcher in the same institution, focusing on Short Bowel Syndrome and epigenetic enzymes in cancer. Marianne has also gained international exposure by working as a Visiting Scientist at the University of Cambridge, Laboratory of Ludovic Vallier, in 2015. Their academic journey began with a Master's thesis at the University of Copenhagen, Institute for Medical Microbiology and Immunology, where they completed their research from November 2003 to May 2006.

Marianne Terndrup Pedersen completed their education at the University of Copenhagen. Marianne Terndrup obtained a Master of Science (MSc) in Biochemistry from 2001 to 2006. Following that, they pursued a Doctor of Philosophy (PhD) degree from 2006 to 2011, although their field of study for the PhD is not specified.